March 11, 2025
AbbVie’s New CEO Rob Michael Earns $18.5M in First Year as Humira Succession Plan Unfolds
AbbVie CEO succession, Rob Michael compensation, Humira patent expiration, Skyrizi and Rinvoq growth, Pharmaceutical executive pay
Lila Sciences Emerges with $200M to Build AI-Powered Scientific Superintelligence Platform
AI, scientific discovery, autonomous labs, Flagship Pioneering, seed funding